title: Evaluation of neonatal sepsis screening in a tropical area. Part II: Evaluation of intrapartum chemoprophylaxis protocol.
abstract: The authors report on an analysis of a chemoprophylaxis protocol at the University Hospital of Guadeloupe in the Caribbean. This study comprised 6,060 consecutive deliveries and was initiated to assess the application of an intrapartum chemoprophylaxis protocol, evaluate its results, and try to identify possible necessary modifications to the existing protocol. Although more than 90% of women had at least one bacterial screening (vaginal or urinary) during the last trimester of pregnancy, approximately 75% of mothers who were heavily colonized group B streptococcus (GBS) at delivery were not detected by this systematic screening. As is also reported in other tropical areas where a great proportion of neonatal sepsis occurs in term babies, low birthweight was not a specific risk factor in this study when controlling for other major risk factors such as fever and premature rupture of membranes. Intrapartum chemoprophylaxis was associated with an approximate threefold decrease in the risk of GBS neonatal bacteraemia among at risk deliveries. The results suggest that, in our tropical context, prolonged rupture of membranes of at least 12 hours' duration should be considered as a cause for intrapartum chemoprophylaxis as it accounted for the majority of cases of neonatal bacteraemia that escaped the existing protocol.
authors.affiliation: Neonatalogy, Centre Hospitalier Sud Réunion, BP 350, 97448 Saint-Pierre, La Réunion, France.
authors.forename: P Y
authors.initials: PY
authors.lastname: Robillard
authors.forename: T C
authors.initials: TC
authors.lastname: Hulsey
authors.forename: J M
authors.initials: JM
authors.lastname: Pérez
authors.forename: J
authors.initials: J
authors.lastname: Périanin
authors.forename: A
authors.initials: A
authors.lastname: Gallais
authors.forename: E
authors.initials: E
authors.lastname: Janky
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D018890:Chemoprevention / Q000379:methods; D002985:Clinical Protocols; D005260:Female; D019430:Guadeloupe / Q000453:epidemiology; D006801:Humans; D007230:Infant, Low Birth Weight / Q000502:physiology; D007231:Infant, Newborn; D007743:Labor, Obstetric; D016015:Logistic Models; D008297:Male; D015997:Neonatal Screening; D011247:Pregnancy; D012307:Risk Factors; D018805:Sepsis / Q000453:epidemiology / Q000517:prevention & control*; D014329:Tropical Climate
chemical_list: D000900:Anti-Bacterial Agents